LRP1B and extranodal nasal NK/T cell lymphoma: Therefore, the higher SV burden of LRP1B in NKTCL patients, especially those relapsed/refractory ones, likely serves to reduce chemotherapy sensitivity and therefore to lead to treatment failures.